The incidence of glioblastoma (GBM) in the elderly population is slowly increasing in
Western countries. Current management includes surgery, radiation therapy (RT) and …

Median age at diagnosis in patients with glioblastoma (GB) is slowly increasing with an
aging population in Western countries, and was 64years in 2006. The number of patients …

PURPOSE: Radiotherapy (RT) and chemotherapy may prolong survival in older patients
(age≥ 70 years) with glioblastoma multiforme (GBM), although the survival benefits remain …

The aim of this study was to evaluate the impact of radiotherapy plus concomitant and
adjuvant temozolomide (TMZ), in terms of feasibility and activity, in elderly patients with …

Although current treatment advances prolong patient survival, treatment for glioblastoma
(GBM) in the elderly has become an emerging issue. The definition of “elderly” differs across …

Importance Despite improvements in survival with aggressive chemoradiation, outcomes for
patients diagnosed as having glioblastoma multiforme (GBM) remain poor. Survival is further …

Objectives The optimal treatment for elderly patients (age> 70 years) with glioblastoma
remains controversial. We conducted a prospective trial in 32 consecutive elderly patients …

Purpose: Elderly patients make up a large percentage of the individuals newly diagnosed
with glioblastoma (gbm), but they face particular challenges in tolerating standard therapy …

Survival of elderly patients with glioblastoma (GBM) is poor, but improves with tumor
resection and radiotherapy (RT). Concurrent temozolomide (TMZ) chemotherapy during RT …

Age remains the most powerful prognostic factor among glioblastoma (GBM) patients. Half of
all patients with GBM are aged 65 years or older at the time of diagnosis, and the incidence …